Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Stock Screener
Compare Stocks
Penny Stock Screener
Top Product Insights Stocks
Daily Updates
Daily Analyst Ratings
Trending Stocks
Top Stock Gainers
Top Stock Losers
Most Active Stocks
Dividend Stocks
ChatGPT Stocks
New
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
Stock Ideas
ETF Research Tools
ETF Center
ETF Screener
Top ETFs by Smart Score
New
Compare ETFs
Top ETFs by AUM
ETFs On the Move
Top ETF Gainers
Top ETF Losers
Most Active ETFs
ETF Ideas
S&P 500 Index ETFs
Nasdaq 100 Index ETFs
S&P 500 Sector ETFs
Bond ETFs
Commodity ETFs
Currency ETFs
Industry ETFs
ETFs
Best Dividend Stocks
Best High Yield Dividend Stocks
Dividend Aristocrats
New
Dividend Stock Comparison
Dividend Calculator
Popular
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
My Portfolio
My Watchlist
My Performance
My Portfolio Analysis
Crowd Insights
Portfolio
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
News
Education
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Careers
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
More...
Plans
News
Smart Portfolio
Expert Center
Ideas
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed Tools
Try Now
Stock Ideas
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Stock Screener
Compare Stocks
Penny Stock Screener
Top Product Insights Stocks
Options Profit Calculator
New
Daily Updates
Daily Analyst Ratings
Trending Stocks
Top Stock Gainers
Top Stock Losers
Most Active Stocks
Dividend Stocks
ChatGPT Stocks
New
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
ETFs
ETF Research Tools
ETF Center
ETF Screener
New
Top ETFs by Smart Score
New
Compare ETFs
Top ETFs by AUM
ETFs On the Move
Top ETF Gainers
Top ETF Losers
Most Active ETFs
ETF Ideas
S&P 500 Index ETFs
Nasdaq 100 Index ETFs
S&P 500 Sector ETFs
Bond ETFs
Commodity ETFs
Currency ETFs
Industry ETFs
Dividends
Best Dividend Stocks
Best High Yield Dividend Stocks
Dividend Aristocrats
New
Dividend Stock Comparison
Dividend Calculator
Popular
Dividend Returns Comparison
Dividend Calendar
Crypto
Crypto Center
Bitcoin
Ethereum
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Portfolio
My Portfolio
My Watchlist
My Performance
My Portfolio Analysis
Crowd Insights
News
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
More
Education
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Careers
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
Plans & Pricing
ZVRA
Stock Latest News
Press Releases
Zevra Therapeutics Reports Corporate Updates and First Quarter 2023 Financial Results
17d ago
ZVRA
Press Releases
Zevra Therapeutics will Participate in RBC Capital Markets Global Healthcare Conference on May 16, 2023
23d ago
ZVRA
Press Releases
Zevra Therapeutics to Report First Quarter 2023 Results on May 15, 2023
24d ago
ZVRA
Press Releases
Zevra Announces Board of Directors and Leadership Changes
25d ago
ZVRA
The Fly
Zevra Therapeutics announces FDA acceptance of IND application for KP1077
30d ago
ZVRA
Press Releases
Zevra Therapeutics Announces FDA Acceptance of IND Application for KP1077 in Narcolepsy
30d ago
ZVRA
The Fly
Zevra Therapeutics management to meet virtually with Cantor Fitzgerald
1M ago
ZVRA
The Fly
Zevra Therapeutics management to meet virtually with Cantor Fitzgerald
1M ago
ZVRA
Press Releases
Leading Proxy Advisory Firms ISS and Glass Lewis Demonstrate Strong Support for Zevra’s Transformation Strategy
2M ago
ZVRA
The Fly
ISS and Glass Lewis support Zevra Therapeutics’ ‘transformation strategy’
2M ago
ZVRA
Press Releases
Zevra Therapeutics Announces Submission of IND for KP1077 in Narcolepsy
2M ago
ZVRA
The Fly
Zevra Therapeutics submits IND for KP1077 in narcolepsy
2M ago
ZVRA
The Fly
Zevra Therapeutics appoints Dixon to board of directors
2M ago
BMY
ZVRA
Press Releases
Zevra Therapeutics Appoints Biopharma Veteran Wendy Dixon, Ph.D., to Board of Directors
2M ago
ZVRA
The Fly
Zevra Therapeutics initiated with a Buy at Maxim
3M ago
ZVRA
Press Releases
Zevra Therapeutics Announces Collaboration with RARE-X and the Sleep Consortium as Founding Member of New Sleep Data Initiative
3M ago
ZVRA
The Fly
Zevra Therapeutics announces collaboration with RARE-X, Sleep Consortium
3M ago
ZVRA
Press Releases
Zevra Therapeutics Files Definitive Proxy Statement and Mails Letter to Shareholders
3M ago
ZVRA
The Fly
Zevra Therapeutics urges shareholders to vote for all director nominees
3M ago
ZVRA
Press Releases
Zevra Therapeutics Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Corporate Updates
3M ago
ZVRA
The Fly
Zevra Therapeutics reports Q4 EPS (26c), consensus (17c)
3M ago
ZVRA
Press Releases
Zevra Therapeutics to Present at 35th Annual Roth Conference
3M ago
ZVRA
Show More
You need to enable JavaScript to run this app.
